Informações:
Falhas:
ID
17190
Descrição
Lingzhi and Sen Miao San for the Treatment of Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT00432484
Link
https://clinicaltrials.gov/show/NCT00432484
Palavras-chave
Versões (1)
- 30/08/2016 30/08/2016 -
Transferido a
30 de agosto de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Rheumatoid Arthritis NCT00432484
Eligibility Rheumatoid Arthritis NCT00432484
- StudyEvent: Eligibility
Similar models
Eligibility Rheumatoid Arthritis NCT00432484
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Rheumatoid Arthritis
Item
fulfilled the 1987 american college of rheumatology (acr) criteria for ra.
boolean
C0003873 (UMLS CUI [1])
swollen/tender joint count
Item
the presence of 2 or more swollen or tender joints, based on 28-joint count.
boolean
C0451521 (UMLS CUI [1])
C0451530 (UMLS CUI [2])
C0451530 (UMLS CUI [2])
morning stiffness
Item
morning stiffness lasting for 30 minutes.
boolean
C0457086 (UMLS CUI [1])
erythrocyte sedimentation rate (esr), treatment with disease modifying agent
Item
erythrocyte sedimentation rate (esr) of 28 mm/hour, despite treatment with disease modifying agent including mtx, sulphasalazine, hydroxychloroquine, auranofin or azathioprine were recruited into the study.
boolean
C1176468 (UMLS CUI [1])
C0242708 (UMLS CUI [2])
C0242708 (UMLS CUI [2])
glucocorticoids and/or nonsteroidal antiinflammatory drugs, stable dosage
Item
patients taking glucocorticoids (prednisone < 7.5 mg/day) and/or nonsteroidal antiinflammatory drugs must have been taking a stable dosage for at least 4 weeks before entering the trial and were required to take the same dosage throughout the trial.
boolean
C0017710 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0003211 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
C0205360 (UMLS CUI [1,2])
C0003211 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
Bone erosion
Item
patients had radiographic erosive diseases.
boolean
C0587240 (UMLS CUI [1])
pregnant or breast feeding
Item
patients who are pregnant or nursing mothers.
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
C0006147 (UMLS CUI [1,2])
Severe liver disease
Item
severe liver disease (e.g cirrhosis, chronic active hepatitis)
boolean
C0023895 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
serum creatinine
Item
renal impairment (serum creatinine level > 150mmol/l)
boolean
C0201976 (UMLS CUI [1])
Hypersensitivity to herbal medicine
Item
known hypersensitivity to herbal medicine
boolean
C0020517 (UMLS CUI [1,1])
C0025125 (UMLS CUI [1,2])
C0025125 (UMLS CUI [1,2])